1. Home
  2. RCKT vs OBK Comparison

RCKT vs OBK Comparison

Compare RCKT & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • OBK
  • Stock Information
  • Founded
  • RCKT 1999
  • OBK 1912
  • Country
  • RCKT United States
  • OBK United States
  • Employees
  • RCKT N/A
  • OBK N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • OBK Major Banks
  • Sector
  • RCKT Health Care
  • OBK Finance
  • Exchange
  • RCKT Nasdaq
  • OBK Nasdaq
  • Market Cap
  • RCKT 1.3B
  • OBK 1.0B
  • IPO Year
  • RCKT N/A
  • OBK 2018
  • Fundamental
  • Price
  • RCKT $10.31
  • OBK $35.11
  • Analyst Decision
  • RCKT Strong Buy
  • OBK Buy
  • Analyst Count
  • RCKT 11
  • OBK 5
  • Target Price
  • RCKT $50.27
  • OBK $36.80
  • AVG Volume (30 Days)
  • RCKT 1.8M
  • OBK 147.1K
  • Earning Date
  • RCKT 02-24-2025
  • OBK 01-22-2025
  • Dividend Yield
  • RCKT N/A
  • OBK 1.71%
  • EPS Growth
  • RCKT N/A
  • OBK N/A
  • EPS
  • RCKT N/A
  • OBK 2.43
  • Revenue
  • RCKT N/A
  • OBK $343,330,000.00
  • Revenue This Year
  • RCKT N/A
  • OBK N/A
  • Revenue Next Year
  • RCKT $240,645.72
  • OBK $3.11
  • P/E Ratio
  • RCKT N/A
  • OBK $14.45
  • Revenue Growth
  • RCKT N/A
  • OBK N/A
  • 52 Week Low
  • RCKT $10.12
  • OBK $27.69
  • 52 Week High
  • RCKT $31.47
  • OBK $37.56
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 32.27
  • OBK 58.95
  • Support Level
  • RCKT $10.12
  • OBK $34.27
  • Resistance Level
  • RCKT $11.24
  • OBK $36.43
  • Average True Range (ATR)
  • RCKT 0.71
  • OBK 0.96
  • MACD
  • RCKT -0.09
  • OBK 0.24
  • Stochastic Oscillator
  • RCKT 5.88
  • OBK 72.09

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

Share on Social Networks: